.webp&w=384&q=75){kind=logo}
Loading, please wait...
Loading, please wait...
The National Health Authority (NHA) is actively driving digital health transformation across India. Specifically, the AB PM-JAY Hackathon 2026 highlights the ongoing effort to modernize the flagship health assurance scheme. Currently, the system processes nearly 50,000 claims daily across more than 1,900 treatment packages. Consequently, the massive scale of operations demands higher speed and accuracy in claims adjudication. While some claims undergo auto-adjudication, the need for a scalable, package-agnostic solution remains significant. Therefore, the NHA seeks advanced systems that can handle diverse document formats and utilize AI-based fraud detection for transparent outcomes.
The AB PM-JAY Hackathon 2026 aims to catalyze innovative digital solutions that integrate with existing healthcare infrastructure. Moreover, this initiative intends to reduce manual effort and accelerate processing timelines for millions of beneficiaries. The NHA has already received an enthusiastic response with over 2,600 registered participants from across the country. Consequently, students, developers, and startups are collaborating to build a future-ready adjudication framework. Furthermore, a specialized Masterclass Series supports these participants in understanding the complex challenge statements provided by the health authority.
The hackathon will culminate in a high-profile, two-day offline finale in May 2026. Specifically, the event will occur at the Indian Institute of Science in Bengaluru on May 8-9. During this finale, teams will present their digital solutions to an eminent jury of healthcare and technology leaders. Additionally, winning teams will receive significant cash prizes ranging from Rs 2 lakh to Rs 5 lakh for each problem statement. Successful innovators also gain the opportunity for potential long-term collaboration with the NHA. This commitment fosters a culture of innovation to improve healthcare delivery for all Indian providers and citizens.
Q1: Who can participate in the AB PM-JAY Hackathon 2026?
Interested students, researchers, developers, professionals, startups, and innovators are eligible to participate in this digital health initiative.
Q2: What are the main rewards for the winners?
Winners will receive cash prizes of Rs 5 lakh, Rs 3 lakh, or Rs 2 lakh, along with opportunities for collaboration with the NHA.
Q3: Where is the final round of the hackathon located?
The grand finale will take place as an offline event at the Indian Institute of Science (IISc) in Bengaluru.
Disclaimer: This content is for informational and educational purposes only. It does not constitute medical advice or replace professional judgment. Refer to the latest local and national guidelines for clinical practice.
References
Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.
Open your smartphone camera to scan and install.
NHA's AB PM-JAY Hackathon 2026 seeks AI solutions to automate health claims, offering cash prizes and collaboration opportunities for digital health innovat...
6 months ago
Review how tailored exercise programs benefit frail older patients with heart failure. Explore pathophysiological mechanisms, individualized training prescriptions, and strategies to overcome adherence barriers in clinical practice.
Today
Leucine Rich Bio has introduced South Asia's first comprehensive vaginal microbiome test, BugSpeaks. By profiling microbial dysbiosis, pathogens, and antimicrobial resistance, this next-generation diagnostic platform provides clinicians with deeper insights into recurrent infections, fertility, and reproductive health.
Today
In high-risk pulmonary embolism complicated by severe anemia and active uterine bleeding, systemic thrombolysis is contraindicated. Large-bore aspiration thrombectomy provides rapid hemodynamic rescue without fibrinolysis, supported by inferior vena cava filter placement and multidisciplinary critical care.
Today
This comparative study evaluates posterior labral tears with and without glenohumeral instability, highlighting distinct demographic patterns, MRI underestimation in stable shoulders, and successful arthroscopic repair outcomes.
Today
A clinical study demonstrates that early intervention with tocilizumab, either as monotherapy or bridged with corticosteroids, achieves significant proptosis reduction and resolves active inflammation in treatment-naive thyroid eye disease.
Today
